{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T02:23:40Z","timestamp":1782440620169,"version":"3.54.5"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1097\/md.0000000000008091","type":"journal-article","created":{"date-parts":[[2017,9,27]],"date-time":"2017-09-27T16:21:01Z","timestamp":1506529261000},"page":"e8091","source":"Crossref","is-referenced-by-count":14,"title":["Clinical characteristics of angioimmunoblastic T-cell lymphoma in China and C-reactive protein as an independent prognostic factor"],"prefix":"10.1097","volume":"96","author":[{"given":"Ying","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-22-20210309","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1182\/blood-2007-08-105759","article-title":"Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte (GELA) trials","volume":"111","author":"Mourad","year":"2008","journal-title":"Blood"},{"key":"R3-22-20210309","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2141.2009.08003.x","article-title":"Advances in the understanding and management of angioimmunoblastic T-cell lymphoma","volume":"148","author":"De Leval","year":"2010","journal-title":"Br J Haematol"},{"key":"R4-22-20210309","doi-asserted-by":"crossref","first-page":"e92585","DOI":"10.1371\/journal.pone.0092585","article-title":"No survival improvement for patients with angioimmunoblastic T-cell lymphoma over the past two decades: A population-based study of 1207 cases","volume":"9","author":"Xu","year":"2014","journal-title":"PLoS One"},{"key":"R5-22-20210309","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","article-title":"Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the International Peripheral T-Cell Lymphoma Project","volume":"3","author":"Federico","year":"2013","journal-title":"J Clin Oncol"},{"key":"R6-22-20210309","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1182\/blood-2011-08-374371","article-title":"Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan","volume":"119","author":"Tokunaga","year":"2012","journal-title":"Blood"},{"key":"R7-22-20210309","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s12185-015-1763-7","article-title":"Analysis of clinical characteristics and prognostic factors for angioimmunoblastic T-cell lymphoma","volume":"101","author":"Kameoka","year":"2015","journal-title":"Int J Hematol"},{"key":"R8-22-20210309","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/annonc\/mdf033","article-title":"Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project","volume":"13","author":"R\u00fcdiger","year":"2002","journal-title":"Ann Oncol"},{"key":"R9-22-20210309","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s12185-016-2010-6","article-title":"Clinical features, outcome and prognostic factors of 87 patients with angioimmunoblastic T cell lymphoma in Taiwan","volume":"104","author":"Kao","year":"2016","journal-title":"Int J Hematol"},{"key":"R10-22-20210309","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1600-0609.2007.00894.x","article-title":"Early-mid treatment C-reactive protein level is a prognostic factor in aggressive non-Hodgkin's lymphoma","volume":"79","author":"Herishanu","year":"2007","journal-title":"Eur J Haematol"},{"key":"R11-22-20210309","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/mpo.10286","article-title":"C-reactive protein (CRP) as tumor marker in pediatric and adolescent patients with Hodgkin disease","volume":"41","author":"Wieland","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"R12-22-20210309","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.bjhh.2015.05.003","article-title":"Evaluation correlates C-reactive protein with advanced stage Hodgkin's lymphoma and response to treatment in a tertiary university hospital in Brazil","volume":"37","author":"Bueno da Silveira da Rocha","year":"2015","journal-title":"Rev Bras Hematol Hemoter"},{"key":"R13-22-20210309","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkins lymphoma.","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"R14-22-20210309","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","article-title":"Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study","volume":"103","author":"Gallamini","year":"2004","journal-title":"Blood"},{"key":"R15-22-20210309","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano Classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"R16-22-20210309","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"R17-22-20210309","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"R18-22-20210309","doi-asserted-by":"crossref","first-page":"e1003251","DOI":"10.1371\/journal.pgen.1003251","article-title":"Inflammation-mediated genetic and epigenetic alterations drive cancer development in the neighboring epithelium upon stromal abrogation of TGF-beta signaling","volume":"9","author":"Achyut","year":"2013","journal-title":"PLoS Genet"},{"key":"R19-22-20210309","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ctrv.2012.07.003","article-title":"Does interleukin-6 link explain the link between tumor necrosis, local and systemic inflammatory responses and outcome in patients with colorectal cancer?","volume":"39","author":"Guthrie","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"R20-22-20210309","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0002-9610(01)00684-5","article-title":"Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma","volume":"182","author":"Nozoe","year":"2001","journal-title":"Am J Surg"},{"key":"R21-22-20210309","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/bjs.4038","article-title":"Systemic inflammatory response predicts survival following curative resection of colorectal cancer","volume":"90","author":"McMillan","year":"2003","journal-title":"Br J Surg"},{"key":"R22-22-20210309","first-page":"966","article-title":"C-reactive protein as a prognostic marker in patients with hepatocellular carcinoma","volume":"62","author":"Kinoshita","year":"2015","journal-title":"Hepatogastroenterology"},{"key":"R23-22-20210309","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/j.1442-2042.2006.01563.x","article-title":"Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma","volume":"13","author":"Ito","year":"2006","journal-title":"Int J Urol"},{"key":"R24-22-20210309","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1200\/JCO.2008.18.9068","article-title":"Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients","volume":"27","author":"Pierce","year":"2009","journal-title":"J Clin Oncol"},{"key":"R25-22-20210309","doi-asserted-by":"crossref","first-page":"441","DOI":"10.5301\/tj.5000522","article-title":"Baseline C-reactive protein level predicts survival of early-stage lung cancer: evidence from a systematic review and meta-analysis","volume":"102","author":"Leuzzi","year":"2016","journal-title":"Tumori"},{"key":"R26-22-20210309","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3109\/10428199809057568","article-title":"High serum interleukin-6 levels correlate with a shorter failure-free survival in indolent lymphoma","volume":"30","author":"Fayad","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"R27-22-20210309","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1365-2141.1998.00538.x","article-title":"Circulating interleukin-6 levels are elevated in adult T-cell leukaemia\/lymphoma patients and correlate with adverse clinical features and survival","volume":"100","author":"Yamamura","year":"1998","journal-title":"Br J Haematol"},{"key":"R28-22-20210309","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00277-014-2167-0","article-title":"The Glasgow Prognostic Score as a significant predictor of diffuse large B cell lymphoma treated with R-CHOP in China","volume":"94","author":"Li","year":"2015","journal-title":"Ann Hematol"},{"key":"R29-22-20210309","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.3349\/ymj.2014.55.6.1568","article-title":"The Modified Glasgow Prognostic Scores as a predictor in diffuse large B cell lymphoma treated with R-CHOP","volume":"55","author":"Kim","year":"2014","journal-title":"Yonsei Med J"},{"key":"R30-22-20210309","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cca.2016.05.033","article-title":"Pretreatment C-reactive protein was an independent prognostic factor for patients with diffuse large B-cell lymphoma treated with RCHOP","volume":"459","author":"Wang","year":"2016","journal-title":"Clin Chim Acta"},{"key":"R31-22-20210309","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/bjc.2014.277","article-title":"C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients","volume":"111","author":"Troppan","year":"2014","journal-title":"Br J Cancer"},{"key":"R32-22-20210309","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/hed.23322","article-title":"Novel and simple prognostic index for nasal natural killer\/T-cell lymphoma","volume":"36","author":"Hanakawa","year":"2014","journal-title":"Head Neck"},{"key":"R33-22-20210309","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/ijlh.12592","article-title":"Serum ferritin level is a prognostic maker in patients with peripheral T-cell lymphoma","volume":"39","author":"Koyama","year":"2017","journal-title":"Int J Lab Hematol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000008091","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:33:57Z","timestamp":1620959637000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201709290-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":32,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000008091","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}